Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Omar Habib

Thoracic Surgery (Cardiothoracic Vascular Surgery) Detroit, MI Medical Doctor

NPI 1689873010 CMS profile 981112

22201 Moross Rd, Suite 356, Detroit, MI 48236

Open in the dashboard

General payments

$20,459

191 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Omar Habib of Detroit, MI is reported in the CMS Open Payments database as having received $20,459 across 191 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,476 43
2024 General $5,158 38
2023 General $2,497 25
2022 General $3,208 31
2021 General $1,918 24
2020 General $569 8
2019 General $2,633 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Omar Habib
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Omar Habib were reported at $4,476. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Omar Habib Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,633 $886 $178–$3,167 $163
2020 $569 $341 $108–$1,605 $114
2021 $1,918 $453 $125–$1,886 $132
2022 $3,208 $695 $180–$2,566 $149
2023 $2,497 $745 $205–$2,662 $160
2024 $5,158 $799 $214–$2,967 $164
2025 $4,476 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $6,925 77 payments
  2. Atricure, Inc. $4,766 37 payments
  3. Edwards Lifesciences Corporation $3,809 27 payments
  4. CryoLife, Inc. $1,766 6 payments
  5. Abiomed $1,688 16 payments
  6. Medtronic Vascular, Inc. $582 10 payments
  7. La Jolla Pharmaceutical Company $215 2 payments
  8. Chiesi USA, Inc. $170 1 payment
  9. Terumo Cardiovascular Systems Corporation $144 2 payments
  10. Maquet Cardiovascular U.S. Sales, L.L.C. $144 2 payments
  11. Other $250 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $15,915 180 payments
  2. Travel and Lodging $4,544 11 payments
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $3,429 41 payments
  2. ATRICLIP LAA EXCLUSION SYSTEM $3,004 18 payments
  3. Avalus $2,747 23 payments
  4. MITRIS RESILIA Mitral Valve $1,980 7 payments
  5. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,865 13 payments
  6. BioGlue $1,627 5 payments
  7. On-X $1,627 5 payments
  8. PhotoFix $1,627 5 payments
  9. AtriCure cryoICE cryoSPHERE Cryoablation System $1,577 6 payments
  10. SYNERGY ABLATION SYSTEM $1,490 13 payments
  11. Other $6,670 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Cardiology: 2,533

Drug cost

$31

Median for Cardiology: $485,213

Branded share of claims

0%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Metoprolol Tartrate Generic 14 $31

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$74,426

Medicare's payments for the services billed

Medicare patients

62

Average age 72

Services billed

207

24 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 60%
Atrial fibrillation 58%
Diabetes 56%
COPD 48%
Arthritis 48%
Chronic kidney disease 39%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

191 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record